Seizert Capital Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-288,046
Closed -$5M 182
2023
Q3
$5M Buy
288,046
+4,313
+2% +$89.9K 0.27% 68
2023
Q2
$5.9M Sell
283,733
-3,600
-1% -$78.2K 0.32% 63
2023
Q1
$6.76M Buy
287,333
+18,010
+7% +$484K 0.37% 63
2022
Q4
$7.52M Sell
269,323
-161,696
-38% -$4.13M 0.4% 59
2022
Q3
$10.1M Sell
431,019
-16,282
-4% -$492K 0.57% 47
2022
Q2
$15.1M Buy
447,301
+51,436
+13% +$1.8M 0.8% 44
2022
Q1
$13.8M Sell
395,865
-72,583
-15% -$2.48M 0.64% 47
2021
Q4
$14.3M Sell
468,448
-60,688
-11% -$1.98M 0.64% 47
2021
Q3
$17.4M Buy
+529,136
New +$16.9M 0.79% 45

Other funds holding OGN

Seizert Capital Partners's OGN Position: Q4 2023 in Review

Seizert Capital Partners sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 288,046 shares — an estimated $5M sold.

Seizert Capital Partners first reported a position in OGN in Q3 2021 and held it in 9 quarters. The position peaked at $17.4M in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Seizert Capital Partners reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Seizert Capital Partners sold 288,046 Organon & Co shares in Q4 2023, an estimated $5M.
  • Seizert Capital Partners first reported a position in Organon & Co in Q3 2021 and held it in 9 quarters.
  • Seizert Capital Partners's Organon & Co position peaked at $17.4M in Q3 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Seizert Capital Partners's 13F filing for Q4 2023, filed 7 Feb 2024.